Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Molecular Genetics and Metabolism
|
March 18, 2014
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology
Gregory A Grabowski, Myriam Golembo, Yoseph Shaaltiel
Plant Biotechnology Journal
|
April 2, 2015
Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease
Yoseph Shaaltiel, Svetlana Gingis-Velitski, Salit Tzaban, et al.
Bioconjugate Chemistry
|
April 27, 2018
Development and Analytical Characterization of Pegunigalsidase Alfa, a Chemically Cross-Linked Plant Recombinant Human α-Galactosidase-A for Treatment of Fabry Disease
Ilya Ruderfer, Avidor Shulman, Tali Kizhner, et al.
World Journal of Gastroenterology
|
November 8, 2016
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
Yaron Ilan, Ami Ben Ya'acov, Yehudit Shabbat, et al.
Bioscience Reports
|
August 29, 2013
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
Yoram Tekoah, Salit Tzaban, Tali Kizhner, et al.
Immunobiology
|
November 12, 2016
A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis
Yaron Ilan, Svetlana Gingis-Velitski, Ami Ben Ya'aco, et al.
Molecular Genetics and Metabolism
|
August 27, 2014
Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease
Tali Kizhner, Yaniv Azulay, Mariana Hainrichson, et al.
Frontiers in Plant Science
|
December 16, 2020
Sequential Genome Editing and Induced Excision of the Transgene in <i>N. tabacum</i> BY2 Cells
Maor Sheva, Uri Hanania, Tami Ariel, et al.
The Journal of Biological Chemistry
|
August 2, 2007
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease
Boris Brumshtein, Harry M Greenblatt, Terry D Butters, et al.
Journal of Immunological Methods
|
April 11, 2017
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
Einat Almon, Tawfik Khoury, Ariel Drori, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Molecular Genetics and Metabolism
|
March 18, 2014
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology
Gregory A Grabowski, Myriam Golembo, Yoseph Shaaltiel
Plant Biotechnology Journal
|
April 2, 2015
Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease
Yoseph Shaaltiel, Svetlana Gingis-Velitski, Salit Tzaban, et al.
Bioconjugate Chemistry
|
April 27, 2018
Development and Analytical Characterization of Pegunigalsidase Alfa, a Chemically Cross-Linked Plant Recombinant Human α-Galactosidase-A for Treatment of Fabry Disease
Ilya Ruderfer, Avidor Shulman, Tali Kizhner, et al.
World Journal of Gastroenterology
|
November 8, 2016
Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
Yaron Ilan, Ami Ben Ya'acov, Yehudit Shabbat, et al.
Bioscience Reports
|
August 29, 2013
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
Yoram Tekoah, Salit Tzaban, Tali Kizhner, et al.
Immunobiology
|
November 12, 2016
A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis
Yaron Ilan, Svetlana Gingis-Velitski, Ami Ben Ya'aco, et al.
Molecular Genetics and Metabolism
|
August 27, 2014
Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease
Tali Kizhner, Yaniv Azulay, Mariana Hainrichson, et al.
Frontiers in Plant Science
|
December 16, 2020
Sequential Genome Editing and Induced Excision of the Transgene in <i>N. tabacum</i> BY2 Cells
Maor Sheva, Uri Hanania, Tami Ariel, et al.
The Journal of Biological Chemistry
|
August 2, 2007
Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease
Boris Brumshtein, Harry M Greenblatt, Terry D Butters, et al.
Journal of Immunological Methods
|
April 11, 2017
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
Einat Almon, Tawfik Khoury, Ariel Drori, et al.
Page
of 2